For the Quarter Ending September 2025
North America
鈥� In the United States, the Dimethylacetamide Price Index slipped quarter over quarter, reflecting muted downstream activity.聽
鈥� Dimethylacetamide Spot Price weakened as coatings and polymer demand remained subdued, with pharma uptake steady but insufficient to offset declines.聽
鈥� Dimethylacetamide Price Forecast points to continued softness, driven by comfortable inventories and steady operating rates.聽
鈥� Dimethylacetamide Production Cost Trend remained flat, supported by stable feedstock and energy inputs.聽
鈥� Dimethylacetamide Demand Outlook stayed cautious, with limited restocking and thin spot inquiries across industrial solvents.聽
鈥� The Price Index reflected balanced supply chains, no feedstock disruptions, and steady logistics.聽
鈥� Regional freight stability kept distribution costs contained, but demand weakness capped upside momentum.
Why did the price of Dimethylacetamide change in September 2025 in North America?聽
鈥� Prices decreased as downstream demand remained weak, inventories were comfortable, and no bullish triggers emerged.聽
鈥� Stable production flows and absence of feedstock constraints tilted the balance in favor of buyers.聽
鈥� Spot activity was muted, reinforcing downward pressure despite steady pharma consumption.
APAC
鈥� In China, the Dimethylacetamide Price Index rose by 0% quarter-over-quarter, reflecting stable market conditions domestically.
鈥� The average Dimethylacetamide price for the quarter was approximately USD 800.67/MT per domestic trading reports.
鈥� Dimethylacetamide Spot Price firmed notably as domestic pharmaceutical demand and industrial solvent uptake strengthened volumes.
鈥� Dimethylacetamide Price Forecast shows modest upside risk linked to sustained downstream purchasing and moderate operating rates.
鈥� Dimethylacetamide Production Cost Trend remained contained despite lower freight costs, with feedstock and energy pressures mixed.
鈥� Dimethylacetamide Demand Outlook improved driven by renewed API production and increased chemical industry consumption domestically.
鈥� Dimethylacetamide Price Index stability reflected steady inventories, balanced export demand, and selective producer supply discipline.
鈥� Regional logistical relief reduced distribution costs but failed to offset tight domestic supply and order-driven output.
Why did the price of Dimethylacetamide change in September 2025 in APAC?
鈥� Renewed domestic pharmaceutical demand increased consumption, tightening supplies and supporting higher spot pricing across regions.
鈥� Moderate operating rates at plants constrained incremental supply while freight cost declines provided limited downward pressure.
鈥� Selective producer output adjustments and firm downstream buying maintained price stability despite softer global logistics costs.
Europe
鈥� In Germany, the Dimethylacetamide Price Index fell quarter over quarter, reflecting subdued industrial activity.聽
鈥� Dimethylacetamide Spot Price softened as textile and coatings demand underperformed, while pharma orders steadied volumes.聽
鈥� Dimethylacetamide Price Forecast suggests range bound movement, with limited upside risk.
鈥� Dimethylacetamide Production Cost Trend remained contained amid stable energy tariffs and feedstock availability.聽
鈥� Dimethylacetamide Demand Outlook was neutral, with patchy sectoral performance.聽
鈥� Price Index stability reflected balanced imports, steady domestic output, and no major supply alerts.聽
鈥� Logistics ran smoothly, reducing distribution costs but failing to offset weak demand.
Why did the price of Dimethylacetamide change in September 2025 in Europe?聽
鈥� Prices decreased marginally as converters delayed purchases and maintained thin safety stocks.聽
鈥� Pharma demand steadied but was insufficient to counter weaker industrial solvent consumption.聽
鈥� Smooth supply chains and balanced inventories reinforced the downward bias.
For the Quarter Ending March 2025
North America
The Dimethylacetamide (DMAC) market showed slightly declining trend during the first quarter, driven by subdued activity in its key downstream sectors鈥攑harmaceuticals and construction. Despite some resilience shown by the pharmaceutical sector, the overall demand remained insufficient to support price growth. While pharma exports remained steady, domestic pharmaceutical consumption plateaued, and market participants adopted on-demand procurement strategies instead of bulk buying, contributing to reduced offtake volumes. This restrained buying behavior kept pressure on DMAC prices, as manufacturers refrained from raising quotations due to sufficient inventory levels and low urgency for replenishment.
Simultaneously, the construction sector in North America remained weak, weighed down by economic uncertainty, higher interest rates, and lower housing starts. This decline in new construction activity directly impacted demand for DMAC -based construction applications, including insulation and coatings. Combined with stable supply conditions and minimal logistic cost fluctuations, the limited momentum from both sectors failed to generate upward pricing pressure.聽
As a result, cautious downstream demand and steady supply dynamics led to a modest yet notable price decline in the region.
EUROPE
In the first quarter of 2025, the DMAC market showed mixed trend as Europe's construction sector exhibited varied trends. While there are signs of a gradual recovery driven by demand for modernized infrastructure and sustainable buildings, certain segments, such as residential construction in Germany, continue to face challenges. Building permits for apartments in Germany declined by 2.3% in February compared to the same month the previous year, indicating ongoing struggles in the property sector.聽
The pharmaceutical industry in Europe is navigating uncertainties due to potential U.S. tariffs on imported medicines. Major pharmaceutical companies have appealed to the European Commission for support to maintain their presence in the EU, highlighting economic disadvantages compared to the U.S. In response to tariff threats, Irish pharmaceutical exports to the U.S. surged by over 450% year-on-year in February, reaching 鈧�10.5 billion, as companies increased shipments to mitigate potential trade barriers.聽
These developments reflect a complex landscape for Europe's construction and pharmaceutical sectors in early 2025, characterized by both opportunities for growth and challenges posed by external economic factors.
APAC
The APAC Dimethylacetamide market in Q1 2025 displayed subdued price fluctuations, indicative of balanced supply chain dynamics and restrained procurement by manufacturers. Demand remained stable, bolstered by consistent consumption in downstream construction and pharmaceutical sectors, despite reduced new order volumes. Freight cost reductions and efficient port operations supported steady trading activities, although sporadic logistical disruptions dampened market momentum. Adequate inventory levels further sustained neutral market sentiment throughout the quarter.
In China, Dimethylacetamide prices fell by 7.87% from Q4 2024 to Q1 2025, averaging USD 804/MT on an FOB-Nanjing basis. Prices demonstrated a flat intra-quarter trend, reflecting stable supply chains and sufficient inventories. Demand from construction remained consistent, while a recovering pharmaceutical sector provided additional support. However, bearish market sentiment prevailed due to limited new order inflows.
Looking ahead, the near-term outlook for the market is cautiously stable, with modest upward potential tied to fluctuations in feedstock costs and anticipated improvements in sectoral demand, particularly from pharmaceuticals and construction.
For the Quarter Ending December 2024
North America
During Q4 2024, the Dimethylacetamide (DMAc) market in North America witnessed moderate growth, fueled by a rise in demand from key sectors like pharmaceuticals, agrochemicals, and textiles. In the pharmaceutical industry, DMAc鈥檚 role as a solvent and catalyst drove consistent consumption, while the agrochemical sector continued to rely on DMAc for various formulations, boosting demand. The textile industry, which uses DMAc for producing high-quality solvents, also contributed positively to market performance.聽
However, the market faced some hurdles, such as fluctuations in raw material costs, which added uncertainty to pricing and profitability. The presence of substitute solvents also posed a challenge, with some industries exploring alternatives to DMAc due to cost or availability considerations.聽
Despite these challenges, the overall outlook for the DMAc market remained optimistic, supported by stable demand from key sectors. The growing applications of DMAc in these industries, combined with an expanding need for its use in production processes, provided a solid foundation for sustained growth throughout the quarter.
APAC
Throughout Q4 2024, the Dimethylacetamide (DMAC) market in China exhibited a bearish trend, primarily driven by weak demand from the pharmaceutical and coating sectors. Despite stable feedstock prices for Dimethyl Amine and Acetic Acid, low demand from key downstream industries suppressed market activity. Inventory levels were sufficient to meet the subdued demand, and market participants focused on destocking efforts to align supply with the lack of strong market interest. The holiday periods in China further dampened market activity, with many producers scaling back operations, leading to reduced trading and cautious procurement behaviors. As a result, market participants refrained from engaging in active purchases, opting instead to deplete existing inventories. The bearish sentiment was further fueled by a decline in new orders and a reluctance to increase quotations amid declining sales and economic uncertainty. Additionally, concerns over global trade outlooks and potential tariffs contributed to the cautious market atmosphere, with stability in prices reflecting the prevailing subdued sentiment and limited demand.
Europe
In Q4 2024, the Dimethylacetamide (DMAc) market in Europe experienced moderate growth, driven by a surge in demand for the commodity from the pharmaceutical and agrochemical sectors, where DMAc plays a crucial role as both a solvent and catalyst. The pharmaceutical industry continued to rely on DMAc for drug formulation, while the agrochemical sector used it in pesticide production. Additionally, the textile industry contributed to market performance due to its need for high-quality solvents in fabric processing and dyeing. However, the market faced challenges, particularly fluctuations in raw material costs, as the prices of feedstocks like Dimethylamine and Acetic Acid varied, impacting overall production costs. The presence of substitute solvents also posed a challenge to DMAc demand, as some industries looked for alternative solutions to reduce costs. Despite these obstacles, the market outlook remained positive, with continued support from the key sectors maintaining steady growth. The demand from these industries helped the market maintain stability, and future growth prospects look optimistic as industrial needs for high-quality solvents persist.
For the Quarter Ending September 2024
North America
In Q3 2024, Dimethylacetamide (DMAC) prices in North America experienced an upward trajectory, with the USA observing the most significant price hikes. This growth stemmed from a combination of factors affecting market dynamics, notably supply constraints and heightened demand from critical downstream sectors. Labor strikes and natural disasters played a pivotal role in tightening the supply of DMAC across the region, as these disruptions impacted both production and transportation channels. This scarcity exerted considerable upward pressure on DMAC prices, with manufacturers struggling to maintain supply amid restricted availability.
Adding to the strain, the Pharmaceutical sector, a primary consumer of Dimethylacetamide, witnessed a surge in demand during the quarter. The pharmaceutical industry which depends on DMAC in various applications, placed additional pressure on an already limited supply and further elevated prices. Feedstock prices for Dimethyl Amine and Acetic Acid, both essential inputs in DMAC production, experienced steady growth throughout Q3, driving up production costs and reinforcing bullish sentiment in the DMAC market.
The combination of supply constraints, strong demand from the pharmaceutical industry, and rising feedstock prices created a tight market environment. Consequently, DMAC prices climbed as suppliers adjusted quotations to reflect these challenging conditions, establishing a notably bullish outlook for the US market in Q3.
APAC
The third quarter of 2024 has been characterized by a persistent downward trend in Dimethylacetamide pricing across the APAC region, with notable influences impacting market prices. Factors such as weakened demand from key downstream sectors, particularly the construction and pharmaceutical industries, have contributed significantly to the declining prices. However, the fluctuations in production costs due to mixed feedstock prices, notably Dimethyl Amine and Acetic Acid, have kept pricing pressures on Dimethylacetamide. In China, the market has experienced the most significant price changes, with a -9% decrease compared to the same quarter last year. The correlation between price changes and seasonality has been evident, with a -7% change from the previous quarter in 2024 and a -4% difference between the first and second half of the quarter. The latest quarter-ending price of USD 950/MT of Dimethylacetamide FOB-Nanjing in China reflects the prevailing negative sentiment in the pricing environment, showcasing a consistent decrease in market prices throughout the quarter.
Europe
In Q3 2024, Europe鈥檚 Dimethylacetamide (DMAC) market faced a marked decline in prices, reflecting a challenging environment shaped by subdued demand and economic uncertainty. Downstream sectors, especially Pharmaceuticals and Construction, witnessed weakened activity due to ongoing economic pressures and reduced consumer spending, resulting in lower demand for DMAC. This decline in usage across critical sectors created an oversupply situation, which intensified the downward pressure on DMAC prices. Interestingly, feedstock prices for Dimethyl Amine and Acetic Acid, essential raw materials for DMAC production, experienced steady growth during the quarter. Rising costs for these inputs pushed up production expenses, yet producers struggled to transfer these costs to end-users amid the unfavorable market sentiment. Consequently, the disconnect between production costs and selling prices weighed on profitability, compelling market players to offer competitive pricing to stimulate limited demand. The result was a bearish pricing environment for DMAC in Europe, with market sentiment dampened by weak downstream demand and economic challenges despite escalating production costs. This combination of factors underscored the difficulties faced by the European DMAC market in Q3.
